Kim, Y.-S. & Brechbiel, M. W. An overview of targeted alpha therapy. Tumor Biol. 33, 573–590 (2012).Article
CAS
Google Scholar
Sgouros, G., Bodei, L., McDevitt, M. R. & Nedrow, J. R. Radiopharmaceutical therapy in cancer: clinical advances and challenges. Nat. Rev. Drug Discov. 19, 589–608 (2020).Article
CAS
PubMed
PubMed Central
Google Scholar
Kramer-Marek, G. & Capala, J. The role of nuclear medicine in modern therapy of cancer. Tumor Biol. 33, 629–640 (2012).Article
CAS
Google Scholar
Poty, S., Francesconi, L. C., McDevitt, M. R., Morris, M. J. & Lewis, J. S. \({{{{{\rm{\alpha }}}}}}\)-Emitters for radiotherapy: from basic radiochemistry to clinical studies—part 1. J. Nucl. Med. 59, 878–884 (2018).Article
CAS
PubMed
PubMed Central
Google Scholar
Geerlings, M. W., Kaspersen, F. M., Apostolidis, C. & van der Hout, R. The feasibility of 225Ac as a source of \({{{{{\rm{\alpha }}}}}}\)-particles in radioimmunotherapy. Nucl. Med. Commun. 14, 121–125 (1993).Article
CAS
PubMed
Google Scholar
McDevitt, M. R. et al. Tumor therapy with targeted atomic nanogenerators. Science 294, 1537–1540 (2001).Article
ADS
CAS
PubMed
Google Scholar
Morgan, K. A., Rudd, S. E., Noor, A. & Donnelly, P. S. Theranostic nuclear medicine with gallium-68, lutetium-177, copper-64/67, actinium-225, and lead-212/203 radionuclides. Chem. Rev. 123, 12004–12035 (2023).Article
CAS
PubMed
Google Scholar
Morgenstern, A., Apostolidis, C. & Bruchertseifer, F. Supply and clinical application of actinium-225 and bismuth-213. Sem. Nucl. Med. 50, 119–123 (2020).Article
Google Scholar
Kratochwil, C. et al. 225Ac-PSMA-617 for PSMA-targeted \({{{{{\rm{\alpha }}}}}}\)-radiation therapy of metastatic castration-resistant prostate cancer. J. Nucl. Med. 57, 1941–1944 (2016).Article
CAS
PubMed
Google Scholar
Boll, R. A., Malkemus, D. & Mirzadeh, S. Production of actinium-225 for alpha particle mediated radioimmunotherapy. Appl Radiat. Isot. 62, 667–679 (2005).Article
CAS
PubMed
Google Scholar
Bruchertseifer, F., Kellerbauer, A., Malmbeck, R. & Morgenstern, A. Targeted alpha therapy with bismuth-213 and actinium-225: Meeting future demand. J. Label. Comp. Radiopharm. 62, 794–802 (2019).Article
CAS
Google Scholar
Thiele, N. A. & Wilson, J. J. Actinium-225 for targeted α therapy: coordination chemistry and current chelation approaches. Cancer Biother Radiopharm. 33, 336–348 (2018).PubMed
PubMed Central
Google Scholar
Jonathan, S., Ken, H. & Lisa, B. The future of targeted \({{{{{\rm{\alpha }}}}}}\)-therapy is bright, but rigorous studies are necessary to advance the field. J. Nucl. Med. 64, 219–220 (2023).Article
Google Scholar
Kirby, H. W. & Morss, L. R. “Actinium” in The Chemistry of the Actinide and Transactinide Elements (eds Morss L. R., Edelstein N. M. & Fuger J.) 18–51 (Springer, 2006).Thiele, N. A. et al. An eighteen-membered macrocyclic ligand for actinium-225 targeted alpha therapy. Angew. Chem. Int. Ed. 56, 14712–14717 (2017).Article
CAS
Google Scholar
Morgenstern, A. et al. Computer-assisted design of macrocyclic chelators for actinium-225 radiotherapeutics. Inorg. Chem. 60, 623–632 (2021).Article
CAS
PubMed
Google Scholar
Yang, H. et al. Harnessing \({{{{{\rm{\alpha }}}}}}\)-emitting radionuclides for therapy: radiolabeling method review. J. Nucl. Med. 63, 5–13 (2022).Article
CAS
PubMed
PubMed Central
Google Scholar
Carbo-Bague, I. et al. Comparative study of a decadentate acyclic chelate, HOPO-O10, and its octadentate analogue, HOPO-O8, for radiopharmaceutical applications. Inorg. Chem. 62, 20549–20566 (2023).Article
CAS
PubMed
Google Scholar
Matazova, E. V. et al. Insights into actinium complexes with tetraacetates─AcBATA versus AcDOTA: thermodynamic, structural, and labeling properties. Inorg. Chem. 62, 12223–12236 (2023).Article
CAS
PubMed
Google Scholar
Aldrich, K. E. et al. Preparation of an actinium-228 generator. Inorg. Chem. 59, 3200–3206 (2020).Article
CAS
PubMed
Google Scholar
Gao, Y., Grover, P. & Schreckenbach, G. Stabilization of hydrated AcIII cation: the role of superatom states in actinium-water bonding. Chem. Sci. 12, 2655–2666 (2021).Article
CAS
PubMed
PubMed Central
Google Scholar
Deblonde, G. J.-P. et al. Capturing an elusive but critical element: natural protein enables actinium chemistry. Sci. Adv. 7, eabk0273 (2021).Article
ADS
CAS
PubMed
PubMed Central
Google Scholar
Ferrier, M. G. et al. Spectroscopic and computational investigation of actinium coordination chemistry. Nat. Commun. 7, 12312 (2016).Article
ADS
CAS
PubMed
PubMed Central
Google Scholar
Ferrier, M. G. et al. Synthesis and characterization of the actinium aquo ion. ACS Cent. Sci. 3, 176–185 (2017).Article
CAS
PubMed
PubMed Central
Google Scholar
Stein, B. W. et al. Advancing chelation chemistry for actinium and other +3 f-elements, Am, Cm, and La. J. Am. Chem. Soc. 141, 19404–19414 (2019).Article
CAS
PubMed
Google Scholar
Jones, Z. R. et al. Advancing understanding of actinide(III) (Ac, Am, Cm) aqueous complexation chemistry. Chem. Sci. 12, 5638–5654 (2021).Article
CAS
PubMed
PubMed Central
Google Scholar
Fried, S., Hagemann, F. & Zachariasen, W. H. The preparation and identification of some pure actinium compounds. J. Am. Chem. Soc. 72, 771–775 (1950).Article
CAS
Google Scholar
Deblonde, G. J. P., Zavarin, M. & Kersting, A. B. The coordination properties and ionic radius of actinium: A 120-year-old enigma. Coord. Chem. Rev. 446, 214130 (2021).Article
CAS
Google Scholar
Abergel, R. J. et al. Biomimetic actinide chelators: an update on the preclinical development of the orally active hydroxypyridonate decorporation agents 3,4,3-LI(1,2-HOPO) and 5-LIO(Me-3,2-HOPO). Health Phys. 99, 401–407 (2010).Article
CAS
PubMed
PubMed Central
Google Scholar
Carter, K. P. et al. Developing scandium and yttrium coordination chemistry to advance theranostic radiopharmaceuticals. Commun. Chem. 3, 61 (2020).Article
CAS
PubMed
PubMed Central
Google Scholar
Sturzbecher-Hoehne, M. et al. 3,4,3-LI(1,2-HOPO): In vitro formation of highly stable lanthanide complexes translates into efficacious in vivo europium decorporation. Dalton Trans. 40, 8340–8346 (2011).Article
CAS
PubMed
Google Scholar
Sturzbecher-Hoehne, M., Yang, P., D’Aléo, A. & Abergel, R. J. Intramolecular sensitization of americium luminescence in solution: shining light on short-lived forbidden 5f transitions. Dalton Trans. 45, 9912–9919 (2016).Article
CAS
PubMed
Google Scholar
Sturzbecher-Hoehne, M., Kullgren, B., Jarvis, E. E., An, D. D. & Abergel, R. J. Highly luminescent and stable hydroxypyridinonate complexes: a step towards new curium decontamination strategies. Chem. Eur. J. 20, 9962–9968 (2014).Article
CAS
PubMed
Google Scholar
Deblonde, G. J. P. et al. Chelation and stabilization of berkelium in oxidation state +IV. Nat. Chem. 9, 843–849 (2017).Article
CAS
PubMed
Google Scholar
Carter, K. P. et al. Structural and spectroscopic characterization of an einsteinium complex. Nature 590, 85–88 (2021).Article
ADS
CAS
PubMed
Google Scholar
Pallares, R. M., Carter, K. P., Faulkner, D. & Abergel, R. J. “Macromolecular crystallography for f-element complex characterization”. In Methods in Enzymology: Rare-Earth Element Biochemistry, Characterization and Applications of Lanthanide-Binding Biomolecules (ed Cotruvo, J. A.) 139–155 (Academic Press, 2021).Goetz, D. H. et al. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol. Cell 10, 1033–1043 (2002).Article
CAS
PubMed
Google Scholar
Allred, B. E. et al. Siderocalin-mediated recognition, sensitization, and cellular uptake of actinides. Proc. Natl. Acad. Sci. USA 112, 10342–10347 (2015).Article
ADS
CAS
PubMed
PubMed Central
Google Scholar
Zielinska, B., Apostolidis, C., Bruchertseifer, F. & Morgenstern, A. An improved method for the production of Ac‐225/Bi‐213 from Th‐229 for targeted alpha therapy. Solvent Extraction Ion. Exch. 25, 339–349 (2007).Article
CAS
Google Scholar
Shannon, R. D. Revised effective ionic radii and systematic studies of interatomic distances in halides and chalcogenides. Acta Crystallogr. A 32, 751–767 (1976).Article
ADS
Google Scholar
Hoette, T. M., Abergel, R. J., Xu, J., Strong, R. K. & Raymond, K. N. The role of electrostatics in siderophore recognition by the immunoprotein siderocalin. J. Am. Chem. Soc. 130, 17584–17592 (2008).Article
CAS
PubMed
PubMed Central
Google Scholar
Kuzmič, P. Program DYNAFIT for the analysis of enzyme kinetic data: application to HIV proteinase. Anal. Biochem. 237, 260–273 (1996).Article
PubMed
Google Scholar
Cosby, A. G. et al. Siderocalin fusion proteins enable a new 86Y/90Y theranostic approach. RSC Chem. Biol. 4, 587–591 (2023).Article
CAS
PubMed
PubMed Central
Google Scholar
Clifton, M. C. et al. Parsing the functional specificity of siderocalin/lipocalin 2/NGAL for siderophores and related small-molecule ligands. J. Struct. Biol. X 2, 100008 (2019).CAS
PubMed
PubMed Central
Google Scholar
Makarova, T., Sinitsyna, G., Stepanov, A., Shestakova, I. & Shestakov, B. Complex formation of actinium. I. Determination of the stability constants of ethylenediaminetetraacetate complexes of actinium and its separation from lanthanum in solutions of EDTA by the method of electromigration. Sov. Radiochem. 14, 555–557 (1972).
Google Scholar
Chatterjee, A., Maslen, E. & Watson, K. The effect of the lanthanoid contraction on the nonaaqualanthanoid(III) tris(trifluoromethanesulfonates). Acta Crystallogr. B 44, 381–386 (1988).Article
ADS
Google Scholar
Kelley, M. P. et al. Bond covalency and oxidation state of actinide ions complexed with therapeutic chelating agent 3,4,3-LI(1,2-HOPO). Inorg. Chem. 57, 5352–5363 (2018).Article
CAS
PubMed
Google Scholar
Nelson, A.-G. D. et al. Further examples of the failure of surrogates to properly model the structural and hydrothermal chemistry of transuranium elements: insights provided by uranium and neptunium diphosphonates. Inorg. Chem. 47, 4945–4951 (2008).Article
CAS
PubMed
Google Scholar
Scerri, E. Which Elements Belong in Group 3 of the Periodic Table? Chem. Int. 38, 22–23 (2016).